Cargando…

Status of radiotherapy in a multidisciplinary cancer board

Multidisciplinary cancer boards (CBs) for making cancer treatment decisions have become popular in many countries; however, the status of radiotherapy in CBs and the influence of CBs on radiotherapy decisions have not been studied. To clarify these issues, we reviewed the minutes of our CBs from Feb...

Descripción completa

Detalles Bibliográficos
Autores principales: Ichikawa, Mayumi, Nemoto, Kenji, Miwa, Misako, Ohta, Ibuki, Nomiya, Takuma, Yamakawa, Mayumi, Itho, Yuriko, Fukui, Tadahisa, Yoshioka, Takashi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3951068/
https://www.ncbi.nlm.nih.gov/pubmed/23979074
http://dx.doi.org/10.1093/jrr/rrt104
_version_ 1782307084982812672
author Ichikawa, Mayumi
Nemoto, Kenji
Miwa, Misako
Ohta, Ibuki
Nomiya, Takuma
Yamakawa, Mayumi
Itho, Yuriko
Fukui, Tadahisa
Yoshioka, Takashi
author_facet Ichikawa, Mayumi
Nemoto, Kenji
Miwa, Misako
Ohta, Ibuki
Nomiya, Takuma
Yamakawa, Mayumi
Itho, Yuriko
Fukui, Tadahisa
Yoshioka, Takashi
author_sort Ichikawa, Mayumi
collection PubMed
description Multidisciplinary cancer boards (CBs) for making cancer treatment decisions have become popular in many countries; however, the status of radiotherapy in CBs and the influence of CBs on radiotherapy decisions have not been studied. To clarify these issues, we reviewed the minutes of our CBs from February 2010 to March 2012, and we classified planned treatments discussed at the CBs into five categories and analyzed decisions concerning radiotherapy in each category. The fraction of cases for which radiotherapy was recommended was 536/757 (71%). These cases included 478 cases (63%) for which radiation therapy was planned and four cases (0.5%) for which radiation therapy was unexpectedly recommended. On the other hand, radiation therapy was canceled in 21 cases (4%) for which radiation therapy had been planned. This study showed that radiotherapy was discussed in many cases at CBs and that CBs have a great influence on decisions concerning radiotherapy.
format Online
Article
Text
id pubmed-3951068
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-39510682014-03-12 Status of radiotherapy in a multidisciplinary cancer board Ichikawa, Mayumi Nemoto, Kenji Miwa, Misako Ohta, Ibuki Nomiya, Takuma Yamakawa, Mayumi Itho, Yuriko Fukui, Tadahisa Yoshioka, Takashi J Radiat Res Oncology Multidisciplinary cancer boards (CBs) for making cancer treatment decisions have become popular in many countries; however, the status of radiotherapy in CBs and the influence of CBs on radiotherapy decisions have not been studied. To clarify these issues, we reviewed the minutes of our CBs from February 2010 to March 2012, and we classified planned treatments discussed at the CBs into five categories and analyzed decisions concerning radiotherapy in each category. The fraction of cases for which radiotherapy was recommended was 536/757 (71%). These cases included 478 cases (63%) for which radiation therapy was planned and four cases (0.5%) for which radiation therapy was unexpectedly recommended. On the other hand, radiation therapy was canceled in 21 cases (4%) for which radiation therapy had been planned. This study showed that radiotherapy was discussed in many cases at CBs and that CBs have a great influence on decisions concerning radiotherapy. Oxford University Press 2014-03 2013-08-26 /pmc/articles/PMC3951068/ /pubmed/23979074 http://dx.doi.org/10.1093/jrr/rrt104 Text en © The Author 2013. Published by Oxford University Press on behalf of The Japan Radiation Research Society and Japanese Society for Therapeutic Radiology and Oncology. http://creativecommons.org/licenses/by-nc/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Oncology
Ichikawa, Mayumi
Nemoto, Kenji
Miwa, Misako
Ohta, Ibuki
Nomiya, Takuma
Yamakawa, Mayumi
Itho, Yuriko
Fukui, Tadahisa
Yoshioka, Takashi
Status of radiotherapy in a multidisciplinary cancer board
title Status of radiotherapy in a multidisciplinary cancer board
title_full Status of radiotherapy in a multidisciplinary cancer board
title_fullStr Status of radiotherapy in a multidisciplinary cancer board
title_full_unstemmed Status of radiotherapy in a multidisciplinary cancer board
title_short Status of radiotherapy in a multidisciplinary cancer board
title_sort status of radiotherapy in a multidisciplinary cancer board
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3951068/
https://www.ncbi.nlm.nih.gov/pubmed/23979074
http://dx.doi.org/10.1093/jrr/rrt104
work_keys_str_mv AT ichikawamayumi statusofradiotherapyinamultidisciplinarycancerboard
AT nemotokenji statusofradiotherapyinamultidisciplinarycancerboard
AT miwamisako statusofradiotherapyinamultidisciplinarycancerboard
AT ohtaibuki statusofradiotherapyinamultidisciplinarycancerboard
AT nomiyatakuma statusofradiotherapyinamultidisciplinarycancerboard
AT yamakawamayumi statusofradiotherapyinamultidisciplinarycancerboard
AT ithoyuriko statusofradiotherapyinamultidisciplinarycancerboard
AT fukuitadahisa statusofradiotherapyinamultidisciplinarycancerboard
AT yoshiokatakashi statusofradiotherapyinamultidisciplinarycancerboard